Related Experiment Video
Updated: Jul 25, 2025

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial
1Department of Paediatric Respiratory Medicine, King's College Hospital, Denmark Hill, London SE5 9RS, United Kingdom.
Insights
Children initially designated Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) may later be diagnosed with Cystic Fibrosis (CF). This highlights the need for ongoing monitoring and re-evaluation of CFSPID cases.
Area of Science:
- Pediatric Pulmonology
- Genetic Diagnosis
- Cystic Fibrosis Research
Background:
- Newborn screening identifies infants with Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID).
- CFSPID designation requires careful monitoring due to potential progression to Cystic Fibrosis (CF).
Observation:
- A case is presented of a child initially designated CFSPID.
- The child later developed recurrent respiratory symptoms and underwent CFTR functional testing.
- Diagnosis was reclassified to CF despite normal sweat chloride levels.
Findings:
- CFTR functional testing and clinical presentation are crucial for diagnosing CF in CFSPID cases.
- Normal sweat chloride levels do not exclude a CF diagnosis in all cases.
- Individual CFTR mutation phenotypes and evolving clinical findings necessitate re-evaluation.
Implications:
- This case underscores the importance of vigilant monitoring for children with CFSPID.
- It provides an approach for challenging the CFSPID designation when CF is suspected.
- Early and accurate diagnosis of CF is critical for timely intervention and management.
Abstract:
We present the case of a child given a CFSPID designation in early life who was later reclassified as having CF based on a combination of recurrent respiratory symptoms and CFTR functional testing, despite normal sweat chloride levels. Here we demonstrate the importance of monitoring these children, each time reviewing the diagnosis based on updated understanding of individual CFTR mutation phenotypes or clinical findings inconsistent with the designation. This case identifies situations in which the CFSPID designation should be challenged, and gives an approach for this when CF is suspected.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Serum Laboratory Studies, Stool Test, Breath Test

